Akari Therapeutics Plc 4
4 · Akari Therapeutics Plc · Filed Sep 22, 2015
Insider Transaction Report
Form 4
Roshwalb Gur
DirectorChief Executive Officer
Transactions
- Award
Options to Purchase Ordinary Shares
2015-09-21+32,543,700→ 32,543,700 totalExercise: $0.32Exp: 2025-09-21→ Ordinary Shares (32,543,700 underlying)
Footnotes (1)
- [F1]The option vests as to 12.5% of the shares on March 18, 2016 and as to an additional 12.5% of the shares on each six month anniversary thereafter over a period of four years from September 18, 2015, provided that Gur Roshwalb remains employed by the Company on the vesting date, and provided further that a minimum of 25% will vest regardless of his employment status. These options will expire 10 years from issuance.